Michael E Silverman, PhD
-
- Position
- ASSOCIATE CLINICAL PROFESSOR | Psychiatry
-
- Specialty
- Psychology
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Silverman a licensed psychologist, dual trained in both psychotherapeutic techniques and cognitive psychology. He has developed and published numerous novel studies probing the relationships between mood, anxiety, behavior and physiologic and neuroanatomic response. Dr. Silverman also has extensive experience in neuropsychiatric and cognitive assessment. His current work focuses primarily on understanding the neuroanatomical, neurobiological and neurofunctional basis of mood change during pregnancy and the period following childbirth. He also has open studies exploring the neuropsychiatric influences of Amyotrophic Lateral Sclorosis (ALS; Lou Gehrig's disease), the neuroanatomic affects of chronic stress, and detailing the cognitive changes as the result of in utero dexamethasone treatment secondary to congenital adrenal hypoplasia risk.
Clinical Focus
- Anxiety
- Depression
- Postpartum Depression
Research Topics
Behavioral Health, Brain, Brain Imaging, Cognitive Neurology, Cognitive Neuroscience, Depression, Memory, Psychiatry, Schizophrenia
Education
PhD, New School for Social Research
Internship, Psychology
Greenery Rehabilitation Center
Internship, Psychology
Concentra Managed Care
Fellowship, Cognitive Psychology
Harvard University
Fellowship, Neuroimaging
New York Presbyterian - Weill Cornell Medical Center
Language
English
Silverman ME, Loudon H, Liu X, Mauro C, Leiter G, Goldstein MA. The neural processing of negative emotion postpartum; a preliminary study of amygdala function in postpartum depression. Arch Womens Ment Health 2011 ; 14(4 ): 355-359.
Savitz DA, Stein CR, Ye F, Kellerman L, Silverman M. The epidemiology of hospitalized postpartum depression in New York State, 1995-2004. Annals of epidemiology 2011 Jun; 21(6): 399-406.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Silverman did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.